GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Consun Pharmaceutical Group Ltd (HKSE:01681) » Definitions » Shiller PE Ratio

Consun Pharmaceutical Group (HKSE:01681) Shiller PE Ratio : 10.92 (As of May. 29, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Consun Pharmaceutical Group Shiller PE Ratio?

As of today (2024-05-29), Consun Pharmaceutical Group's current share price is HK$6.66. Consun Pharmaceutical Group's E10 for the fiscal year that ended in Dec23 was HK$0.61. Consun Pharmaceutical Group's Shiller PE Ratio for today is 10.92.

The historical rank and industry rank for Consun Pharmaceutical Group's Shiller PE Ratio or its related term are showing as below:

HKSE:01681' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.76   Med: 9   Max: 11.44
Current: 10.92

During the past 12 years, Consun Pharmaceutical Group's highest Shiller PE Ratio was 11.44. The lowest was 6.76. And the median was 9.00.

HKSE:01681's Shiller PE Ratio is ranked better than
85.23% of 535 companies
in the Drug Manufacturers industry
Industry Median: 24.13 vs HKSE:01681: 10.92

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Consun Pharmaceutical Group's adjusted earnings per share data of for the fiscal year that ended in Dec23 was HK$1.072. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.61 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Consun Pharmaceutical Group Shiller PE Ratio Historical Data

The historical data trend for Consun Pharmaceutical Group's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Consun Pharmaceutical Group Shiller PE Ratio Chart

Consun Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 9.81 7.61 7.85

Consun Pharmaceutical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.81 - 7.61 - 7.85

Competitive Comparison of Consun Pharmaceutical Group's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Consun Pharmaceutical Group's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Consun Pharmaceutical Group's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Consun Pharmaceutical Group's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Consun Pharmaceutical Group's Shiller PE Ratio falls into.



Consun Pharmaceutical Group Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Consun Pharmaceutical Group's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6.66/0.61
=10.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Consun Pharmaceutical Group's E10 for the fiscal year that ended in Dec23 is calculated as:

For example, Consun Pharmaceutical Group's adjusted earnings per share data for the fiscal year that ended in Dec23 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec23 (Change)*Current CPI (Dec23)
=1.072/114.7809*114.7809
=1.072

Current CPI (Dec23) = 114.7809.

Consun Pharmaceutical Group Annual Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.263 99.000 0.305
201512 0.300 100.600 0.342
201612 0.359 102.600 0.402
201712 0.542 104.500 0.595
201812 0.602 106.500 0.649
201912 0.100 111.200 0.103
202012 0.723 111.500 0.744
202112 0.894 113.108 0.907
202212 0.960 115.116 0.957
202312 1.072 114.781 1.072

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Consun Pharmaceutical Group  (HKSE:01681) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Consun Pharmaceutical Group Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Consun Pharmaceutical Group's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Consun Pharmaceutical Group (HKSE:01681) Business Description

Traded in Other Exchanges
Address
71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN
Consun Pharmaceutical Group Ltd is a biotechnology company with sales operations throughout China. Its principal activities are making and selling pharmaceutical products. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.
Executives
An Yubao 2101 Beneficial owner
Li Qian 2101 Beneficial owner
Central Success Developments Limited 2101 Beneficial owner
Aali Resources Limited 2201 Interest of corporation controlled by you
Bos Trustee Limited 2301 Trustee
Zhang Lihua 2202 Interest of your spouse
An Meng 2101 Beneficial owner
Double Grace International Limited 2101 Beneficial owner
Bos Trustee Limited As Trustee 2201 Interest of corporation controlled by you

Consun Pharmaceutical Group (HKSE:01681) Headlines

No Headlines